The Digital Breast Tomosynthesis Equipment Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End-User (Hospitals, Diagnostic Centers, Others).
In 2024, the market for digital breast tomosynthesis (DBT) equipment addresses the evolving needs of breast cancer screening and diagnosis, offering advanced imaging systems and technology for three-dimensional mammography, breast imaging, and early breast cancer detection. Digital breast tomosynthesis is an imaging technique that uses low-dose X-rays and specialized equipment to create three-dimensional images of the breast tissue, allowing radiologists to visualize breast anatomy with improved clarity, resolution, and tissue separation compared to traditional two-dimensional mammography. DBT equipment combines digital mammography technology with tomographic imaging capabilities, enabling radiologists to detect small breast lesions, improve cancer detection rates, and reduce false-positive findings by eliminating overlapping breast tissue artifacts. With a focus on breast cancer screening accuracy, radiation dose optimization, and patient comfort, DBT equipment undergoes rigorous performance testing, image quality assessment, and regulatory clearance to ensure compliance with industry standards and guidelines. Moreover, with advancements in detector technology, image reconstruction algorithms, and workflow integration features, the digital breast tomosynthesis market continues to innovate, offering enhanced imaging systems, diagnostic tools, and software solutions for improving breast cancer detection, diagnosis, and patient outcomes in breast imaging centers and healthcare facilities.
A prominent trend in the digital breast tomosynthesis equipment market is the increasing adoption of 3D mammography for improved breast cancer detection. Digital breast tomosynthesis (DBT), also known as 3D mammography, offers superior imaging capabilities compared to traditional 2D mammography by capturing multiple images of the breast from different angles, allowing for clearer visualization of breast tissue and lesions. This technology enables radiologists to detect breast cancers earlier, reduce false positives, and improve overall diagnostic accuracy, leading to better patient outcomes. As healthcare providers recognize the clinical benefits of DBT in breast cancer screening and diagnosis, there is a growing demand for digital breast tomosynthesis equipment to replace or complement existing mammography systems, driving market growth in the segment.
A key driver for the digital breast tomosynthesis equipment market is the emphasis on early detection and screening for breast cancer. Breast cancer is one of the most common cancers among women worldwide, with early detection being crucial for successful treatment and improved survival rates. Screening mammography plays a vital role in detecting breast cancer at an early stage when it is most treatable, and digital breast tomosynthesis offers enhanced sensitivity and specificity compared to conventional mammography, particularly in women with dense breast tissue. With increasing awareness of the importance of regular breast cancer screening and advances in imaging technology, there is a growing demand for digital breast tomosynthesis equipment to facilitate more accurate and effective breast cancer screening programs, driving market growth in the segment.
An opportunity for innovation and market differentiation in the digital breast tomosynthesis equipment market lies in the integration of artificial intelligence (AI) for image analysis. AI-based algorithms have the potential to enhance the diagnostic capabilities of digital breast tomosynthesis by assisting radiologists in detecting and characterizing breast lesions more accurately and efficiently. By leveraging machine learning and deep learning techniques, manufacturers can develop AI-powered software solutions that analyze DBT images, highlight suspicious areas, and provide quantitative metrics to aid radiologists in interpreting mammograms and making diagnostic decisions. Additionally, AI algorithms can help improve workflow efficiency, reduce interpretation time, and standardize image interpretation across different healthcare settings. By embracing AI technology and developing innovative software solutions, companies can capitalize on this opportunity to enhance the diagnostic performance of digital breast tomosynthesis equipment and offer value-added solutions to healthcare providers, ultimately driving market growth in the segment.
The Standalone 3D Mammography Systems segment within the Digital Breast Tomosynthesis Equipment market is experiencing rapid growth due to several factors contributing to the increasing adoption of advanced breast imaging technologies and the demand for more accurate and reliable breast cancer screening methods. Standalone 3D mammography systems offer superior imaging capabilities compared to traditional 2D mammography and 2D/3D combination systems, providing clearer, more detailed images of breast tissue with reduced overlap and improved lesion visibility. This enhanced imaging quality leads to better sensitivity and specificity in detecting breast abnormalities, including small masses and architectural distortions, while reducing false positives and unnecessary recalls. Additionally, standalone 3D mammography systems offer workflow efficiencies and faster examination times, making them attractive options for hospitals, diagnostic centers, and other healthcare facilities. The growing emphasis on early detection and personalized medicine in breast cancer care, coupled with advancements in digital breast tomosynthesis technology and reimbursement support for screening and diagnostic procedures, further drive the demand for standalone 3D mammography systems. With ongoing research and development efforts aimed at improving image quality, reducing radiation dose, and expanding clinical applications, this segment is poised for significant growth in the Digital Breast Tomosynthesis Equipment market, contributing to improved breast cancer detection and patient outcomes.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAnalogic Corp, Fujifilm Holdings Corp, GE Healthcare, General Medical Merate SpA, Hologic Inc, Internazionale Medico Scientifica S.r.l, Metaltronica Spa, PerkinElmer Inc, Planmed OY, Siemens Healthineers AG, Trivitron Healthcare, Varex Imaging Corp
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Analogic Corp
Fujifilm Holdings Corp
GE Healthcare
General Medical Merate SpA
Hologic Inc
Internazionale Medico Scientifica S.r.l
Metaltronica Spa
PerkinElmer Inc
Planmed OY
Siemens Healthineers AG
Trivitron Healthcare
Varex Imaging Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Digital Breast Tomosynthesis Equipment Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Digital Breast Tomosynthesis Equipment Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Digital Breast Tomosynthesis Equipment Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Digital Breast Tomosynthesis Equipment Market Size Outlook, $ Million, 2021 to 2030
3.2 Digital Breast Tomosynthesis Equipment Market Outlook by Type, $ Million, 2021 to 2030
3.3 Digital Breast Tomosynthesis Equipment Market Outlook by Product, $ Million, 2021 to 2030
3.4 Digital Breast Tomosynthesis Equipment Market Outlook by Application, $ Million, 2021 to 2030
3.5 Digital Breast Tomosynthesis Equipment Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Digital Breast Tomosynthesis Equipment Industry
4.2 Key Market Trends in Digital Breast Tomosynthesis Equipment Industry
4.3 Potential Opportunities in Digital Breast Tomosynthesis Equipment Industry
4.4 Key Challenges in Digital Breast Tomosynthesis Equipment Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Digital Breast Tomosynthesis Equipment Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Digital Breast Tomosynthesis Equipment Market Outlook by Segments
7.1 Digital Breast Tomosynthesis Equipment Market Outlook by Segments, $ Million, 2021- 2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
8 North America Digital Breast Tomosynthesis Equipment Market Analysis and Outlook To 2030
8.1 Introduction to North America Digital Breast Tomosynthesis Equipment Markets in 2024
8.2 North America Digital Breast Tomosynthesis Equipment Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Digital Breast Tomosynthesis Equipment Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
9 Europe Digital Breast Tomosynthesis Equipment Market Analysis and Outlook To 2030
9.1 Introduction to Europe Digital Breast Tomosynthesis Equipment Markets in 2024
9.2 Europe Digital Breast Tomosynthesis Equipment Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Digital Breast Tomosynthesis Equipment Market Size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
10 Asia Pacific Digital Breast Tomosynthesis Equipment Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Digital Breast Tomosynthesis Equipment Markets in 2024
10.2 Asia Pacific Digital Breast Tomosynthesis Equipment Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Digital Breast Tomosynthesis Equipment Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
11 South America Digital Breast Tomosynthesis Equipment Market Analysis and Outlook To 2030
11.1 Introduction to South America Digital Breast Tomosynthesis Equipment Markets in 2024
11.2 South America Digital Breast Tomosynthesis Equipment Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Digital Breast Tomosynthesis Equipment Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
12 Middle East and Africa Digital Breast Tomosynthesis Equipment Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Digital Breast Tomosynthesis Equipment Markets in 2024
12.2 Middle East and Africa Digital Breast Tomosynthesis Equipment Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Digital Breast Tomosynthesis Equipment Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Analogic Corp
Fujifilm Holdings Corp
GE Healthcare
General Medical Merate SpA
Hologic Inc
Internazionale Medico Scientifica S.r.l
Metaltronica Spa
PerkinElmer Inc
Planmed OY
Siemens Healthineers AG
Trivitron Healthcare
Varex Imaging Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End-User
Hospitals
Diagnostic Centers
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Digital Breast Tomosynthesis Equipment Market is one of the lucrative growth markets, poised to register a 14.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Analogic Corp, Fujifilm Holdings Corp, GE Healthcare, General Medical Merate SpA, Hologic Inc, Internazionale Medico Scientifica S.r.l, Metaltronica Spa, PerkinElmer Inc, Planmed OY, Siemens Healthineers AG, Trivitron Healthcare, Varex Imaging Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume